View in EDS HTML Full Text PDF Full Text

Dasatinib discontinuation in patients with chronic-phase chronic myeloid leukemia and stable deep molecular response: the DASFREE study.

Saved in:
Bibliographic Details
Title: Dasatinib discontinuation in patients with chronic-phase chronic myeloid leukemia and stable deep molecular response: the DASFREE study.
Authors: Shah, Neil P.1 (AUTHOR) neil.shah@ucsf.edu, García-Gutiérrez, Valentín2 (AUTHOR), Jiménez-Velasco, Antonio3 (AUTHOR), Larson, Sarah4 (AUTHOR), Saussele, Susanne5 (AUTHOR), Rea, Delphine6 (AUTHOR), Mahon, François-Xavier7 (AUTHOR), Levy, Moshe Yair8 (AUTHOR), Gómez-Casares, María Teresa9 (AUTHOR), Pane, Fabrizio10 (AUTHOR), Nicolini, Franck-Emmanuel11 (AUTHOR), Mauro, Michael J.12 (AUTHOR), Sy, Oumar13 (AUTHOR), Martin-Regueira, Patricia13 (AUTHOR), Lipton, Jeffrey H.14 (AUTHOR)
Source: Leukemia & Lymphoma. Mar2020, Vol. 61 Issue 3, p650-659. 10p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:10428194
DOI:10.1080/10428194.2019.1675879